100 Migraine Drugs, A to Z: flurbiprofen

February 2, 2019

Flurbiprofen is just another nonsteroidal antiinflammatory drug (NSAID), which is reflected in the name of its branded version – Ansaid. All NSAIDs can relieve acute pain of migraine and some have been proven to prevent attacks if taken on a daily basis. Aspirin, ibuprofen, ketoprofen and naproxen are some of the NSAIDs that have been shown to prevent migraines.

Flurbiprofen is not one of the more popular NSAID drugs, however it was tested for the prevention of migraines in a double-blind placebo-controlled crossover trial. The trial involved 23 patients who were given first placebo or 100 mg of flurbiprofen twice a day for 8 weeks and after a 2-week “washout” period switched (crossed over) from placebo to flurbiprofen and from flurbiprofen to placebo. Flurbiprofen significantly reduced migraine intensity, total hours with migraine, and the dosing frequency of relief (abortive) medications. Total hours with migraine decreased by 41%, and the use of abortive medications decreased by 31%.

Even though this trial involved a small number of patients, very similar mechanism of action to other NSAIDs suggests that flurbiprofen, like other NSAIDs, is an effective preventive agent. However, the reason they are not widely used for this purpose is their safety. They all can cause stomach upset and peptic ulcers, which can bleed and even cause death. They can also cause kidney damage and in those predisposed to heart disease, increase the risk of heart attacks (except for aspirin). On the other hand, millions of arthritis sufferers take these drugs for years with good effect. Because the majority of migraine sufferers are young healthy people, NSAIDs should be used more widely, especially considering that serious side effects can also occur from other preventive drugs such as topiramate (Topamax), divalproex sodium (Depakote), antidepressants, and other.

My pet peeve is the mistaken notion that triptans and NSAIDs is a frequent cause of medication overuse headaches and the fact that NSAIDs taken daily prevent rather than worsen migraines helps refute this myth.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe